The role of Tau, amyloid-β and neuroinflammation in the association between cognition and white matter hyperintensities in a southeast Asian cohort

This publication has 56 references indexed in Scilit:

• Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer's disease and related dementias and the impact of health‐related comorbidities in a community‐dwelling cohort
  Alzheimer's & Dementia, 2024
• Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study
  GeroScience, 2023
• Association between plasma Alzheimer’s disease markers and MRI markers of cerebral small vessel disease and neurodegeneration: the SMART‐MR Study
  Alzheimer's & Dementia, 2022
• Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia
  JAMA Neurology, 2022
• A population‐based meta‐analysis of circulating GFAP for cognition and dementia risk
  Annals of Clinical and Translational Neurology, 2022
• Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort
  Alzheimer's & Dementia, 2022
• Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology
  Acta Neuropathologica, 2021
• Assessment of Plasma Amyloid-β_42/40and Cognitive Decline Among Community-Dwelling Older Adults
  JAMA Network Open, 2020
• Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease
  Acta Neuropathologica, 2017
• Prevalence of Amyloid PET Positivity in Dementia Syndromes
  JAMA, 2015